tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Evolus reports Q3 EPS (24c), consensus (18c)
PremiumThe FlyEvolus reports Q3 EPS (24c), consensus (18c)
4d ago
Evolus’s Potential Amid Market Challenges: Buy Rating Supported by Undervaluation and Growth Prospects
Premium
Ratings
Evolus’s Potential Amid Market Challenges: Buy Rating Supported by Undervaluation and Growth Prospects
16d ago
Needham medtech & diagnostics analysts hold analyst/industry conference call
Premium
The Fly
Needham medtech & diagnostics analysts hold analyst/industry conference call
1M ago
Evolus submits Evolysse premarket approval application to FDA
PremiumThe FlyEvolus submits Evolysse premarket approval application to FDA
3M ago
Evolus, Inc. Advances Safety Study of NUCEIVA for Glabellar Lines
Premium
Company Announcements
Evolus, Inc. Advances Safety Study of NUCEIVA for Glabellar Lines
3M ago
Evolus, Inc. Faces Financial Instability Amid Economic Uncertainty and Consumer Spending Risks
Premium
Company Announcements
Evolus, Inc. Faces Financial Instability Amid Economic Uncertainty and Consumer Spending Risks
3M ago
Evolus cut to Hold at Needham after ‘significant’ Jeuveau downturn
PremiumThe FlyEvolus cut to Hold at Needham after ‘significant’ Jeuveau downturn
3M ago
Evolus downgraded to Hold from Buy at Needham
Premium
The Fly
Evolus downgraded to Hold from Buy at Needham
3M ago
Evolus price target lowered to $20 from $27 at H.C. Wainwright
Premium
The Fly
Evolus price target lowered to $20 from $27 at H.C. Wainwright
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100